Twitter
Link your Twitter Account to Market Wire News
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ACRX - AcelRx PharmaceuticalsEPS of $0.48 revenue of $0.57M beats by $0.02M
August, 11 2022 04:02 PM
AcelRx Pharmaceuticals Inc.
AcelRx Pharmaceuticals press release ( NASDAQ: ACRX ): Q2 EPS of $0.48 may not be comparable to consensus of -$0.06. Revenue of $0.57M (+29.5% Y/Y) beats by $0.02M . Projected annual savings of $9 million beginning in June 2022 from realigned cost structure $84.1 million gain on extinguishment of debt due to termination of royalty monetization For further details see:
AcelRx PharmaceuticalsEPS of $0.48, revenue of $0.57M beats by $0.02M
Stock Information
Company Name:
AcelRx Pharmaceuticals Inc.
Stock Symbol:
ACRX
Market:
NASDAQ
Website:
acelrx.com
Get ACRX Alerts
News, Short Squeeze, Breakout and More Instantly...
Market Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer .